{"version":"1.0","provider_name":"The Medical Xchange","provider_url":"https:\/\/themedicalxchange.com\/fr\/","title":"Des traitements sans interf\u00e9ron dirig\u00e9s contre l\u2019h\u00e9patite C sont en voie d\u2019homologation : donn\u00e9es issues d\u2019\u00e9tudes de Phase III - The Medical Xchange","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"1wNnSPs4Xa\"><a href=\"https:\/\/themedicalxchange.com\/fr\/2014\/05\/23\/semaine-des-maladies-digestives-de-2014-digestiv-2\/\">Des traitements sans interf\u00e9ron dirig\u00e9s contre l\u2019h\u00e9patite C sont en voie d\u2019homologation : donn\u00e9es issues d\u2019\u00e9tudes de Phase III<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/themedicalxchange.com\/fr\/2014\/05\/23\/semaine-des-maladies-digestives-de-2014-digestiv-2\/embed\/#?secret=1wNnSPs4Xa\" width=\"600\" height=\"338\" title=\"\u00ab\u00a0Des traitements sans interf\u00e9ron dirig\u00e9s contre l\u2019h\u00e9patite C sont en voie d\u2019homologation : donn\u00e9es issues d\u2019\u00e9tudes de Phase III\u00a0\u00bb &#8212; The Medical Xchange\" data-secret=\"1wNnSPs4Xa\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script type=\"text\/javascript\">\n\/* <![CDATA[ *\/\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/\/# sourceURL=https:\/\/themedicalxchange.com\/wp-includes\/js\/wp-embed.min.js\n\/* ]]> *\/\n<\/script>\n","thumbnail_url":"https:\/\/themedicalxchange.com\/wp-content\/uploads\/2014\/05\/EX_7007_DDW_FR_Fig_1.PNG","thumbnail_width":960,"thumbnail_height":720,"description":"Chicago \u2013 Il fait de moins en moins de doute que des sch\u00e9mas th\u00e9rapeutiques exempts d\u2019interf\u00e9ron (IFN) dirig\u00e9s contre le virus de l\u2019h\u00e9patite C (VHC) seront homologu\u00e9s sous peu. Une s\u00e9rie d\u2019\u00e9tudes pr\u00e9sent\u00e9es dans le cadre de conf\u00e9rences d\u2019importance majeure au cours des derniers mois, dont la Semaine des maladies digestives de 2014, ont \u00e9tabli un parall\u00e8le entre les plus efficaces de ces traitements et des taux de r\u00e9ponse virologique soutenue (RVS) sup\u00e9rieurs \u00e0 90 %, et ce m\u00eame chez des patients infect\u00e9s par un g\u00e9notype du VHC particuli\u00e8rement r\u00e9fractaire chez lesquels les traitements ant\u00e9rieurs avaient \u00e9chou\u00e9."}